Soberanes S, Misharin AV, Jairaman A, Morales-Nebreda L, McQuattie-Pimentel AC, Cho T, Hamanaka RB, Meliton AY, Reyfman PA, Walter JM, Chen CI, Chi M, Chiu S, Gonzalez-Gonzalez FJ, Antalek M, Abdala-Valencia H, Chiarella SE, Sun KA, Woods PS, Ghio AJ, Jain M, Perlman H, Ridge KM, Morimoto RI, Sznajder JI, Balch WE, Bhorade SM, Bharat A, Prakriya M, Chandel NS, Mutlu GM, Scott Budinger GR
A sort of cultural shorthand for any and all of the GLP-1 medications revolutionizing diabetes and obesity treatment, its in the news and on the minds of millions for good reason
Work-up was negative for coagulopathy or toxicologic etiology
Tesamorelin : Targets visceral fat and improves metabolic function
IR, incidence rate